bioRxiv Science⌕ Search

Biology subjects

Ramdas, B.

Publications and source records attributed to Ramdas, B..

2 recordsLinked to original sources

SSMD: A semi-supervised approach for a robust cell type identification and deconvolution of mouse transcriptomics data

Deconvolution of mouse transcriptomic data is challenged by the fact that mouse models carry various genetic and physiological perturbations, making it questionable to assume fixed cell types and cell type marker genes for different dataset scenarios. We developed a Semi-Supervised Mouse data Deconvolution (SSMD) method to study the mouse tissue microenvironment (TME). SSMD is featured by (i) a novel non-parametric method to discover data set specific cell type signature genes; (ii) a community detection approach for fixing cell types and their marker genes; (iii) a constrained matrix decomposition method to solve cell type relative proportions that is robust to diverse experimental platforms. In summary, SSMD addressed several key challenges in the deconvolution of mouse tissue data, including: (1) varied cell types and marker genes caused by highly divergent genotypic and phenotypic conditions of mouse experiment, (2) diverse experimental platforms of mouse transcriptomics data, (3) small sample size and limited training data source, and (4) capable to estimate the proportion of 35 cell types in blood, inflammatory, central nervous or hematopoietic systems. In silico and experimental validation of SSMD demonstrated its high sensitivity and accuracy in identifying (sub) cell types and predicting cell proportions comparing to state-of-the-arts methods. A user-friendly R package and a web server of SSMD are released via https://github.com/xiaoyulu95/SSMD. Key pointsO_LIWe provide a novel tissue deconvolution method, namely SSMD, which is specifically designed for mouse data to handle the variations caused by different mouse strain, genetic and phenotypic background, and experimental platforms. C_LIO_LISSMD is capable to detect data set and tissue microenvironment specific cell markers for more than 30 cell types in mouse blood, inflammatory tissue, cancer, and central nervous system. C_LIO_LISSMD achieve much improved performance in estimating relative proportion of the cell types compared with state-of-the-art methods. C_LIO_LIThe semi-supervised setting enables the application of SSMD on transcriptomics, DNA methylation and ATAC-seq data. C_LIO_LIA user friendly R package and a R shiny of SSMD based webserver are also developed. C_LI

bioinformatics↗

Mutant p53 Drives Clonal Hematopoiesis through Modulating Epigenetic Pathway

Clonal hematopoiesis of indeterminate potential (CHIP) increases with age and is associated with increased risks of hematological malignancies. While TP53 mutations have been identified in CHIP, the molecular mechanisms by which mutant p53 promotes hematopoietic stem and progenitor cell (HSPC) expansion are largely unknown. We discovered that mutant p53 confers a competitive advantage to HSPCs following transplantation and promotes HSPC expansion after radiation-induced stress. Mechanistically, mutant p53 interacts with EZH2 and enhances its association with the chromatin, thereby increasing the levels of H3K27me3 in genes regulating HSPC self-renewal and differentiation. Further, genetic and pharmacological inhibition of EZH2 decrease the repopulating potential of p53 mutant HSPCs. Thus, we have uncovered an epigenetic mechanism by which mutant p53 drives clonal hematopoiesis. Our work will likely establish epigenetic regulator EZH2 as a novel therapeutic target for preventing CHIP progression and treating hematological malignancies with TP53 mutations.

cancer biology↗